Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Insulin Syringes market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Insulin Syringes market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Insulin Syringes market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Insulin Syringes products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Insulin Syringes products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Insulin Syringes market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Insulin Syringes development has been the leading industry trend of Insulin Syringes market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Insulin Syringes Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
3/10 cc syringe,1/2 cc syringe,1 cc syringe,Others |
| By Application Outlook |
Hospital,Homecare,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Novo Nordisk,Sanofi,Eli Lilly and Company,Biocon Ltd,Ypsomed AG,Wockhardt Ltd,Medtronic Plc,Abbott Laboratories,Animas Corporation,F. Hoffmann-La Roche,BD |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Novo Nordisk
- Sanofi
- Eli Lilly and Company
- Biocon Ltd
- Ypsomed AG
- Wockhardt Ltd
- Medtronic Plc
- Abbott Laboratories
- Animas Corporation
- F. Hoffmann-La Roche
- BD
Insulin Syringes Market, By Type
- 3/10 cc syringe
- 1/2 cc syringe
- 1 cc syringe
- Others
Insulin Syringes Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Insulin Syringes Market Size Growth Rate by Type (2019-2025)
1.3.2 3/10 cc syringe
1.3.3 1/2 cc syringe
1.3.4 1 cc syringe
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Insulin Syringes Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Homecare
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insulin Syringes Market Size
2.1.1 Global Insulin Syringes Revenue 2014-2025
2.1.2 Global Insulin Syringes Sales 2014-2025
2.2 Insulin Syringes Growth Rate by Regions
2.2.1 Global Insulin Syringes Sales by Regions 2014-2019
2.2.2 Global Insulin Syringes Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Insulin Syringes Sales by Manufacturers
3.1.1 Insulin Syringes Sales by Manufacturers 2014-2019
3.1.2 Insulin Syringes Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Insulin Syringes Revenue by Manufacturers (2014-2019)
3.2.2 Insulin Syringes Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Insulin Syringes Market Concentration Ratio (CR5 and HHI)
3.3 Insulin Syringes Price by Manufacturers
3.4 Key Manufacturers Insulin Syringes Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Insulin Syringes Market
3.6 Key Manufacturers Insulin Syringes Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 3/10 cc syringe Sales and Revenue (2014-2019)
4.1.2 1/2 cc syringe Sales and Revenue (2014-2019)
4.1.3 1 cc syringe Sales and Revenue (2014-2019)
4.1.4 Others Sales and Revenue (2014-2019)
4.2 Global Insulin Syringes Sales Market Share by Type
4.3 Global Insulin Syringes Revenue Market Share by Type
4.4 Insulin Syringes Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Insulin Syringes Sales by Application
6 United States
6.1 United States Insulin Syringes Breakdown Data by Company
6.2 United States Insulin Syringes Breakdown Data by Type
6.3 United States Insulin Syringes Breakdown Data by Application
7 European Union
7.1 European Union Insulin Syringes Breakdown Data by Company
7.2 European Union Insulin Syringes Breakdown Data by Type
7.3 European Union Insulin Syringes Breakdown Data by Application
8 China
8.1 China Insulin Syringes Breakdown Data by Company
8.2 China Insulin Syringes Breakdown Data by Type
8.3 China Insulin Syringes Breakdown Data by Application
9 Rest of World
9.1 Rest of World Insulin Syringes Breakdown Data by Company
9.2 Rest of World Insulin Syringes Breakdown Data by Type
9.3 Rest of World Insulin Syringes Breakdown Data by Application
9.4 Rest of World Insulin Syringes Breakdown Data by Countries
9.4.1 Rest of World Insulin Syringes Sales by Countries
9.4.2 Rest of World Insulin Syringes Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Insulin Syringes
10.1.4 Insulin Syringes Product Introduction
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Insulin Syringes
10.2.4 Insulin Syringes Product Introduction
10.2.5 Sanofi Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Insulin Syringes
10.3.4 Insulin Syringes Product Introduction
10.3.5 Eli Lilly and Company Recent Development
10.4 Biocon Ltd
10.4.1 Biocon Ltd Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Insulin Syringes
10.4.4 Insulin Syringes Product Introduction
10.4.5 Biocon Ltd Recent Development
10.5 Ypsomed AG
10.5.1 Ypsomed AG Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Insulin Syringes
10.5.4 Insulin Syringes Product Introduction
10.5.5 Ypsomed AG Recent Development
10.6 Wockhardt Ltd
10.6.1 Wockhardt Ltd Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Insulin Syringes
10.6.4 Insulin Syringes Product Introduction
10.6.5 Wockhardt Ltd Recent Development
10.7 Medtronic Plc
10.7.1 Medtronic Plc Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Insulin Syringes
10.7.4 Insulin Syringes Product Introduction
10.7.5 Medtronic Plc Recent Development
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Insulin Syringes
10.8.4 Insulin Syringes Product Introduction
10.8.5 Abbott Laboratories Recent Development
10.9 Animas Corporation
10.9.1 Animas Corporation Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Insulin Syringes
10.9.4 Insulin Syringes Product Introduction
10.9.5 Animas Corporation Recent Development
10.10 F. Hoffmann-La Roche
10.10.1 F. Hoffmann-La Roche Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Insulin Syringes
10.10.4 Insulin Syringes Product Introduction
10.10.5 F. Hoffmann-La Roche Recent Development
10.11 BD
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Syringes Sales Channels
11.2.2 Insulin Syringes Distributors
11.3 Insulin Syringes Customers
12 Market Forecast
12.1 Global Insulin Syringes Sales and Revenue Forecast 2019-2025
12.2 Global Insulin Syringes Sales Forecast by Type
12.3 Global Insulin Syringes Sales Forecast by Application
12.4 Insulin Syringes Forecast by Regions
12.4.1 Global Insulin Syringes Sales Forecast by Regions 2019-2025
12.4.2 Global Insulin Syringes Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
